multi-modal guided radiotherapy
Showing 1 - 25 of >10,000
Breast Cancer Trial in Shanghai (Fixed positions of arm down and arm up)
Recruiting
- Breast Cancer
- Fixed positions of arm down and arm up
-
Shanghai, Shanghai, ChinaShanghai Proton and Heavy Ion Center
May 18, 2023
MRI Guided Radiotherapy and Radiobiological Data: ISRAR Database
Not yet recruiting
- Prostate Cancer
- +4 more
- 3 MRI sequences (T2*, IVIM and Multi Echo-Gradient), without injection, are performed
- (no location specified)
Sep 18, 2023
Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Apalutamide
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023
Lung Cancer Stage III Trial (ctDNA)
Not yet recruiting
- Lung Cancer Stage III
- ctDNA
- (no location specified)
Oct 26, 2023
Prostate Cancer Trial in Chicago (SBRT to whole prostate, IMRT followed by mpMRI guided SBRT boost with SIB to intraprostatic
Active, not recruiting
- Prostate Cancer
- SBRT to whole prostate
- IMRT followed by mpMRI guided SBRT boost with SIB to intraprostatic lesions
-
Chicago, IllinoisRush University Medical Center
Jan 24, 2021
guided Disease managEment Plan to prevEnt CAD in Patients
Not yet recruiting
- Coronary Artery Disease
- Coronary CT
- (no location specified)
Feb 1, 2023
Bladder Cancer, Urinary Bladder Tumor, Urologic Tumors Trial in Los Angeles, Boston (Fiducial marker placement, Multiparametric
Recruiting
- Bladder Cancer
- +4 more
- Fiducial marker placement
- Multiparametric MRI (mpMRI)
-
Los Angeles, California
- +1 more
Jan 7, 2022
Comparing the Analgesic Outcome by ( 4 in 1 Block ) & ( Adductor Canal Block ) Trial (adductor canal block, 4 in one block)
Not yet recruiting
- Comparing the Analgesic Outcome by ( 4 in 1 Block ) & ( Adductor Canal Block )
- adductor canal block
- 4 in one block
- (no location specified)
Mar 20, 2023
Cancer Trial in Edmonton (MR guided radiotherapy)
Recruiting
- Cancer
- MR guided radiotherapy
-
Edmonton, Alberta, CanadaCross Cancer Institute
Jan 18, 2023
NSCLC Trial in Guangzhou (Unity-based MR-Linac guided FSRT)
Recruiting
- Non-small Cell Lung Cancer
- Unity-based MR-Linac guided FSRT
-
Guangzhou, Guangdong, ChinaHui Liu
Nov 25, 2022
Mental Disorders: Application of a Multi-modal & Domains System
Not yet recruiting
- Mental Disorder
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Jul 2, 2023
Vulvar Cancer Trial in Beijing (optical surface monitoring system)
Completed
- Vulvar Cancer
- optical surface monitoring system
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 2, 2023
Invasiveness for Small-sized Lung Adenocarcinoma
Recruiting
- Lung Adenocarcinoma, Stage I
- Invasiveness diagnosis
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Apr 13, 2023
Preterm Birth, Infant, Premature, Diseases Trial in Ambala (Sensory Stimulation, Movement therapy, Routine hospital care)
Completed
- Preterm Birth
- Infant, Premature, Diseases
- Sensory Stimulation
- +2 more
-
Ambala, Haryana, IndiaNeonatal Intensive Care Unit, Maharishi Markandeshwar Hospital
Jan 15, 2022
Pancreatic Adenocarcinoma Trial in Baltimore (TraceIT tissue marker injection)
Completed
- Pancreatic Adenocarcinoma
- TraceIT tissue marker injection
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 20, 2023
AI Based Multi-modal Parameter of Peripheral Blood Cells
Recruiting
- Children
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Sep 12, 2023
Cancer Trial in Columbia (Exercise)
Enrolling by invitation
- Cancer
- Exercise
-
Columbia, South CarolinaUniversity of South Carolina
Sep 12, 2023
Non-obstructive Azoospermia Trial in New York (Gabapentin, Placebo)
Completed
- Non-obstructive Azoospermia
- Gabapentin
- Placebo
-
New York, New YorkWeill Cornell Medicine
Jan 24, 2023
Outcome in Colorectal Liver Metastases
Completed
- The Characteristics of Patients With Colorectal Cancer Liver Metastasis Who Would Benefit More From Bevacizumab
- Deep radiomics-based fusion model
-
Shanghai, ChinaDepartment of General Surgery, Zhongshan Hospital, Fudan Univers
Aug 29, 2023
Trauma Injury Trial in Houston (Standard of care, Dronabinol)
Not yet recruiting
- Trauma Injury
- Standard of care
- Dronabinol
-
Houston, TexasThe University of Texas Health Science Center at Houston
Apr 6, 2023
Bone Metastases Trial in Palo Alto (MR- High intensity focused ultrasound, External beam radiotherapy)
Not yet recruiting
- Bone Metastases
- MR- High intensity focused ultrasound
- External beam radiotherapy
-
Palo Alto, CaliforniaStanford University
Jun 10, 2022
High Risk of Stroke Trial in Hangzhou (Usual Diet advice, ORIENT diet intervention)
Not yet recruiting
- High Risk of Stroke
- Usual Diet advice
- ORIENT diet intervention
-
Hangzhou, Zhejiang, ChinaSecond Affilated Hospital of Zhejiang University, School of Medi
Oct 19, 2023
MRLinac Boost for Gynecological Cancers if Brachytherapy is Not
Recruiting
- Cervical Cancer
- Gynecologic Cancer
-
Odense, Denmark
- +1 more
Jun 30, 2023
Breast Cancer Trial in Nanjing (precision breast conserving surgery guided by wire guided localization combined with MDCT guided
Completed
- Breast Cancer
- precision breast conserving surgery guided by wire guided localization combined with MDCT guided 3D reconstruction
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jan 29, 2023
Early Stage NSCLC, NSCLC Trial in Saint Louis (Computed tomography-guided stereotactic adaptive radiotherapy, ETHOS)
Not yet recruiting
- Early Stage Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Computed tomography-guided stereotactic adaptive radiotherapy
- ETHOS
-
Saint Louis, MissouriWashington University School of Medicine
Mar 14, 2023